Suppr超能文献

益生菌治疗老年便秘患者的疗效和安全性:系统评价和荟萃分析。

Efficacy and Safety of Probiotics in Geriatric Patients with Constipation: Systematic Review and Meta-Analysis.

机构信息

Shuangping Li, Gansu Provincial Cancer Hospital, 2 Xiaoxihu East Street, Qilihe District, Lanzhou, China. Emails:

出版信息

J Nutr Health Aging. 2023;27(11):1140-1146. doi: 10.1007/s12603-023-2028-4.

Abstract

BACKGROUND

Probiotics may be an effective alternative to traditional drug therapy for constipation in the elderly.

OBJECTIVE

To assess the efficacy and safety of probiotics in managing constipation among the elderly.

METHODS

Eight databases were queried for randomized controlled trials (RCTs) investigating probiotics' efficacy in addressing constipation among the elderly until January 2023. The meta-analysis was conducted employing R software version 4.2.2. The Cochrane risk of bias tool was utilized to evaluate the risk of bias, and the GRADE approach was employed to assess the credibility of the evidence concerning the efficacy of probiotics in treating constipation in older individuals.

RESULTS

A total of six RCTs involving 444 patients were included. Two studies were rated as low risk of bias. The meta-analysis findings revealed that probiotics, when compared to a placebo, led to an increase in stool frequency (MD = 1.02,95% CI [0.21, 2.07], p<0.05, very low quality), the probiotic group exhibited a notable impact on ameliorating symptoms associated with constipation (OR = 11.28, 95%CI [7.21, 17.64], p < 0.05, very low quality), no significant disparities were observed in terms of efforts to evacuate, manual maneuvers, and the incidence of adverse events (p>0.05).

CONCLUSION

The available evidence indicates a degree of uncertainty, ranging from low-to-very low, suggesting the efficacy of probiotics in augmenting bowel frequency and ameliorating constipation-related symptoms among elderly patients with constipation. Nevertheless, given the quality of the studies included, it is advisable to conduct further well-designed investigations with substantial sample sizes to substantiate the findings of this study.

摘要

背景

益生菌可能是治疗老年人便秘的一种有效替代传统药物治疗的方法。

目的

评估益生菌治疗老年人便秘的疗效和安全性。

方法

检索了截至 2023 年 1 月的 8 个数据库,以寻找关于益生菌治疗老年人便秘疗效的随机对照试验(RCT)。使用 R 软件版本 4.2.2 进行荟萃分析。使用 Cochrane 偏倚风险工具评估偏倚风险,并使用 GRADE 方法评估关于益生菌治疗老年人便秘疗效的证据的可信度。

结果

共纳入 6 项 RCT,涉及 444 名患者。其中 2 项研究被评为低偏倚风险。荟萃分析结果显示,与安慰剂相比,益生菌组的粪便频率增加(MD=1.02,95%CI[0.21, 2.07],p<0.05,极低质量),益生菌组对改善便秘相关症状有显著影响(OR=11.28,95%CI[7.21, 17.64],p<0.05,极低质量),在排便努力、手动操作和不良事件发生率方面没有显著差异(p>0.05)。

结论

现有证据存在一定程度的不确定性,从低到极低不等,表明益生菌在增加便秘老年人的排便频率和改善便秘相关症状方面具有一定的疗效。然而,鉴于纳入研究的质量,建议进行进一步的精心设计、大样本量的研究,以证实本研究的结果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验